SNY · Sanofi ADR
United States · RS rating 73 · As of 2026-11-03
| Price | 45.33 USD |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 73 / 89 / 77 / 43 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 39 / 28 / 18 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | -128.7% |
| Sales growth Q/Q | -7.3% |
| Distance from 52-week high | +13.4% |
| Market cap (USD) | $113.9B |